World Chronic Myeloid Leukemia Day: Today, Together We are Treated, Tomorrow We Need Cure

World Chronic Myeloid Leukemia Day is celebrated on 22nd September because 9/22 represents the chromosomal translocation between 9 and 22(Philadelphia Chromosome.

World Chronic Myeloid Leukemia Day is observed on 22nd September to raise awareness about the condition. The theme for this year´s World CML Day is "Today, Together, Today, together we are treated. Tomorrow, we need cure!"

The day is celebrated on 22nd September because 9/22 represents the chromosomal translocation between 9 and 22 (Philadelphia Chromosome). CML patient organizations in 30 countries marked September 22nd as the World CML day.

Chronic Myeloid Leukemia
Chronic myeloid Leukemia is one of the most common types of blood cancer. It is characterized by excess of WBC stem cells in the bone marrow.

‘The theme for this year´s World Chronic Myeloid Leukemia Day is "Today, Together, Today, together we are treated. Tomorrow, we need cure!"’

Following the motto "All united, all unique", their aim is to raise public awareness about CML and provide information on the journey of CML patients, their needs and challenges.

CML is a rare hematological disease that represents 15 to 20 percent of all leukemia cases in adults.

CML Day is an opportunity to spread the word and raise the profile of cancer in people’s minds, in the world’s media, and on the global health and development agenda.

New Approach Being Explored for the Treatment of Chronic Myeloid Leukemia
A new approach in the treatment of chronic myeloid leukemia when used along with tyrosine kinase inhibitors may cure chronic myeloid leukemia.

"WORLD CML DAY (Chronic Myeloid Leukemia) is observed make a difference in the fight against cancer. If CML patients take medicine regularly with regular monitoring this cancer can be controlled successfully with the hope of CURE in the near future," said Dr. Sadashivudu Gundeti, Additional Professor NIMS hospital.

Facts About Chronic Myeloid Leukemia (CML)

Imatinib (Glivec) Resistance in Chronic Myeloid Leukemia Can be Now Detected Early
A major diagnostic breakthrough in the field of chronic myloid leukemia treatment will help identify patients who are resistant to treatment with Glivec.

Nearly 10% of all new cases of leukemia are CML
About 8,950 new cases will be diagnosed with CML
About 1,080 people will die of CML
One person in 555 will get CML in their lifetime
In India, CML accounts for 30% to 60% of all adult leukemias

Source-Medindia

New Drug Combination Promises Better Treatment Outcomes in Chronic Myeloid Leukemia (CML)
Treatment with imatinib and peginterferon alfa-2a was associated with significantly higher rates of molecular responses in people with CML.